Arcis, a Warrington, Cheshire, UK-based R&D company developing new technologies for durable antimicrobial applications across multiple sectors, raised £1.7m in funding.
Calculus Capital invested £1.25m in the round, which followed previous investments totalling £2m made in May 2012 and June 2013.
The company intends to use the funds to develop the business in two areas: DNA extraction (BioApps) and nematicide products (Agriculture).
Led by Peter Whitehurst, CEO, and Geoff Vinall, Executive Chairman, Arcis develops BioApps, which provides DNA extraction products used for molecular diagnostics, and agriculture products such as nematicides, which are pesticides used to kill nematodes, microscopic worms that attack root systems of plants causing poor growth and reduction in crop yields.
Arcis markets its products globally, via a number of partners which distribute them.